AGS-16M8F

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGS-16M8F, covering 2012-12-12 to 2012-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer [Phase 1]

See pricing